Welcome to LookChem.com Sign In|Join Free

CAS

  • or
3-Azabicyclo[3.1.0]hexane-6-carboxamide is a cyclic amine derivative with the molecular formula C6H10N2O. It is a heterocyclic compound, featuring a six-membered ring with one nitrogen atom and five carbon atoms. The nitrogen atom is incorporated into the ring structure, and the molecule contains an amide functional group attached to the sixth carbon atom. 3-Azabicyclo[3.1.0]hexane-6-carboxaMide is of interest in organic chemistry and may have potential applications in the synthesis of pharmaceuticals or other chemical products due to its unique structure and reactivity. It is important to note that the specific properties, reactivity, and applications of 3-azabicyclo[3.1.0]hexane-6-carboxamide would depend on its stereochemistry and the presence of any substituents on the ring.

848488-89-1

Post Buying Request

848488-89-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

848488-89-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 848488-89-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,8,4,8 and 8 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 848488-89:
(8*8)+(7*4)+(6*8)+(5*4)+(4*8)+(3*8)+(2*8)+(1*9)=241
241 % 10 = 1
So 848488-89-1 is a valid CAS Registry Number.

848488-89-1Upstream product

848488-89-1Downstream Products

848488-89-1Relevant articles and documents

6-(3-AZA-BICYCLO[3.1.0]HEX-3-YL)-2-PHENYL-PYRIMIDINES

-

Page/Page column 58, (2010/11/03)

The present invention relates to 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidine derivatives and their use as P2Y12 receptor antagonists in the treatment and/or prevention of peripheral vascular, of visceral-, hepatic- and renal-vascular, of cardiovascular and of cerebrovascular diseases or conditions associated with platelet aggregation, including thrombosis in humans and other mammals.

QUINAZOLINE DERIVATIVES

-

Page/Page column 133, (2008/06/13)

The invention concerns quinazoline derivatives of Formula (I) wherein each of R1, R3, R20, X1, X2, Z, W, (a) and (q) have any of the meanings defined in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an antiproliferative agent in the prevention or treatment of turnours which are sensitive to inhibition of erbB receptor tyrosine kinases, particularly EGFR tyrosine kinase.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 848488-89-1